Nanoparticulate systems for the delivery of antisense oligonucleotides

被引:152
作者
Lambert, G [1 ]
Fattal, E [1 ]
Couvreur, P [1 ]
机构
[1] Fac Pharm Chatenay Malabry, URA CNRS 8612, Lab Phys Chim Pharmacotech & Biopharm, F-92296 Chatenay Malabry, France
关键词
nanoparticles; nanocapsules; nanospheres; oligonucleotide; antisense;
D O I
10.1016/S0169-409X(00)00116-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antisense oligonucleotides are molecules that are able to inhibit gene expression being therefore potentially active for the treatment of viral infections or cancer, However, because of their poor stability in biological medium and their weak intracellular penetration, colloidal drugs carriers such as nanoparticles were developed for the delivery of oligonucleotides (ODN). ODN associated to nanoparticles were shown to be protected against degradation and to penetrate more easily into different types of cells. As a consequence, nanoparticles were shown to improve the efficiency of ODNs for the inhibition of the proliferation of cells expressing the point mutated Ha-ras gene. In vivo, polyalkylcyanoacrylate (PACA) nanoparticles were able to efficiently distribute the ODNs to the liver whereas the alginate nanosponges could concentrate the ODNs in the lungs. Finally, ODN loaded to PACA nanoparticles were able to improve in mice, the treatment of RAS cells expressing the point mutated Ha-ras gene, (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 112
页数:14
相关论文
共 50 条
[21]   Nanoparticulate systems for brain delivery of drugs [J].
Kreuter, J .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :65-81
[22]   Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA [J].
Fattal, Elias ;
Bochot, Amelie .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) :1203-1223
[23]   Increased uptake of antisense oligonucleotides by delivery as double stranded complexes [J].
Astriab-Fisher, A ;
Fisher, MH ;
Juliano, R ;
Herdewijn, P .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (03) :403-407
[24]   A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides [J].
Hussain, M ;
Shchepinov, MS ;
Sohail, M ;
Benter, IF ;
Hollins, AJ ;
Southern, EM ;
Akhtar, S .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (01) :139-155
[25]   Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues [J].
Gait, MJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (05) :844-853
[26]   Delivery of radioiodinated antisense oligonucleotides in long circulating liposomes in vivo [J].
Ma, Chao ;
Lin, Jizheng ;
Xie, Jiawei ;
Wang, Guoming ;
Zuo Shuyao .
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2011, 113 (09) :1106-1112
[27]   Dendrimer conjugates for light-activated delivery of antisense oligonucleotides [J].
Yuan, Ahu ;
Hu, Yiqiao ;
Ming, Xin .
RSC ADVANCES, 2015, 5 (44) :35195-35200
[28]   Molecular Mechanisms of Antisense Oligonucleotides [J].
Crooke, Stanley T. .
NUCLEIC ACID THERAPEUTICS, 2017, 27 (02) :70-77
[29]   Light-Activated Nanodiamond-Based Drug Delivery Systems for Spatiotemporal Release of Antisense Oligonucleotides [J].
Leung, Hoi Man ;
Liu, Ling Sum ;
Cai, Yuzhen ;
Li, Xinru ;
Huang, Yizhi ;
Chu, Hoi Ching ;
Chin, Y. Rebecca ;
Lo, Pik Kwan .
BIOCONJUGATE CHEMISTRY, 2024, 35 (05) :623-632
[30]   Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides [J].
Lambert, G ;
Fattal, E ;
Pinto-Alphandary, H ;
Gulik, A ;
Couvreur, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 214 (1-2) :13-16